This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Agency for Science, Technology and Research. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ching-Wen Huang: Innovator in Antibody Development
Introduction
Ching-Wen Huang is a notable inventor based in Singapore, recognized for his contributions to the field of biotechnology. His work primarily focuses on the development of antibodies that target specific proteins, which can have significant implications in medical research and treatment.
Latest Patents
Ching-Wen Huang holds a patent for Glypican-3 (GPC-3) antibodies. This patent describes an antibody or antigen-binding fragment that comprises a heavy chain variable region (V) sequence and a light chain variable region (V) sequence from a selected clone. The antibody is capable of specifically binding to glypican-3 (GPC-3), which is crucial for various therapeutic applications.
Career Highlights
Huang is affiliated with the Agency for Science, Technology and Research, where he has been instrumental in advancing research in antibody technology. His innovative approach has led to the development of unique antibody sequences that can be utilized in targeted therapies.
Collaborations
Ching-Wen Huang has collaborated with esteemed colleagues, including Cheng-I Wang and Bei Wang, to further enhance the research and development of antibody-based solutions. Their combined expertise has contributed to significant advancements in the field.
Conclusion
Ching-Wen Huang's work in antibody development exemplifies the innovative spirit of modern biotechnology. His contributions are paving the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile